ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 15.3% during mid-day trading on Monday . The stock traded as high as GBX 4.95 ($0.06) and last traded at GBX 4.54 ($0.06). Approximately 21,528,732 shares traded hands during mid-day trading, an increase of 9% from the average daily volume of 19,785,813 shares. The stock had previously closed at GBX 3.94 ($0.05).
ImmuPharma Stock Down 20.3 %
The firm has a market capitalization of £19.57 million, a P/E ratio of -470.00 and a beta of 1.53. The business’s 50 day moving average is GBX 1.92 and its two-hundred day moving average is GBX 1.78.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- How to Use the MarketBeat Excel Dividend Calculator
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- What Does the Future Hold for Eli Lilly?
- Short Selling – The Pros and Cons
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
